Melanoma Posts on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

Nivolumab treatment is associated with an improved survival in advanced melanoma

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the effect of nivolumab (Opdivo) in patients with progressive melanoma after ipilimumab (Yervoy) treatment. Researchers suggested that nivolumab treatment is associated with better response compared with chemotherapy. Some background Recent new therapies, such as immunotherapy, have changed the treatment of...

Read More

Treatment with PD-1 agents improves melanoma outcomes

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell This review investigated the effectiveness of PD-1 agents in the treatment of melanoma. Researchers suggested that treatment with these agents is associated with improved cancer outcomes.   Some background The best treatment for melanoma remains to be determined, however surgery may be associated with a high cure rate. Patients...

Read More

Does age effect immunotherapy treatment in melanoma?

Posted by on Oct 16, 2017 in Melanoma | 0 comments

In a nutshell The study examined if age played a role in the effect of immunotherapy treatment on patients with melanoma. The study concluded that immunotherapy is similarly effective in patients of all ages. Some background Immunotherapy is a type of treatment which targets the immune system to help it to fight cancer. A specific type of...

Read More

Can Video Gaming Build Resilience? You Decide…

Can Video Gaming Build Resilience?   You Decide…

Posted by on Sep 20, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke | 0 comments

In the aftermath of Hurricanes Harvey and Irma, a recent news story discussed the mental health consequences of disasters. Researcher Jean Rhodes of University of Massachusetts Boston studied the mental health of young parents living in New Orleans before and after Hurricane Katrina. RISK- Resilience In Survivors of Katrina is the project’s name. An...

Read More

How safe and effective is chemotherapy given through the limb in elderly melanoma patients?

Posted by on Sep 13, 2017 in Melanoma | 0 comments

In a nutshell This study looked at the safety and effectiveness of isolated limb infusion in elderly patients with melanoma of the skin on a limb (arm/leg) that could not be surgically removed. The study found isolated limb infusion to be safe and effective in elderly patients.  Some background lsolated limb perfusion (ILP) is a method of...

Read More

Factors of survival and treatment in mucosal melanoma

Posted by on Sep 8, 2017 in Melanoma | 0 comments

In a nutshell This study examined factors associated with treatment and survival in patients with mucosal melanoma (cancer of the moist inner lining surfaces of the body). The study concluded that mucosal melanoma may have a poor prognosis due to late diagnosis. However, certain treatments may improve survival rates. Some background Mucosal...

Read More

Dabrafenib combined with trametinib in the treatment of melanoma brain metastasis

Posted by on Aug 21, 2017 in Melanoma | 0 comments

In a nutshell This review examined the effectiveness of dabrafenib (Tafinlar) and trametinib (Mekinist) for BRAF mutated melanoma with brain metastasis. Researchers concluded that this combined treatment is an important therapy option for patients with advanced melanoma. Some background Some melanoma patients have a mutation (permanant change) in...

Read More

Dabrafenib combined with trametinib is associated with durable responses in metastatic melanoma

Posted by on Jun 28, 2017 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness and safety of combined treatment with dabrafenib (Tafinlar) and trametinib (Mekinist) in patients with BRAF mutated stage 3 or 4 melanoma. Researchers suggested that the combination treatment has durable (3 years or more) results.   Some background Patients with metastatic (spread to...

Read More